Tom Heintzelman

Tom Heintzelman, PhD, is currently the Western Region Business Development Manager at Intelligent since August 2020. Prior to this role, Tom served as a Medical Science Liaison at Iverson Genetics from June 2011 to August 2020, focusing on pharmacogenetics and pharmacoeconomic data, as well as KOL identification and clinical trial site management. Tom's earlier experience includes a position as Business Development and Medical Science Liaison for the Central Region of the US and Canada at NMT Medical from February 2000 to 2011, where responsibilities involved promoting a device for congenital heart defect repair and collaborating with KOLs on neurological condition studies. Tom holds a Doctor of Philosophy (Ph.D.) and an MBA from Capella University, University of Missouri Kansas City, and the University of Kansas.